Skip to content

Solidion Technology, Inc. STI Deferred offering costs

Deferred offering costs at other companies

Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$164.72K
Hitachi logo
HitachiHIT
$170.98K
NextNRG, Inc. Common Stock logo
NextNRG, Inc. Common StockNXXT
$18.09K-98.8%
IRA
Iris Acquisition IRAB
$0
Bain Capital Specialty Finance logo
Bain Capital Specialty FinanceBCSF
$3.29M-24.2%
DeFi Development Corp. Common Stock logo
DeFi Development Corp. Common StockDFDV
$3.36M+2,861%

Other financials

Income statement

See full
Revenue$85.4K
Gross profit$83.7K
Operating income-$1.8M+43.4%
Net income-$1.4M-116%
EPS (diluted)-$0.18+40.0%

Balance sheet

See full
Cash & equivalents$38.9K-96.7%
Total debt$527.5K
Total equity-$8.3M+32.1%
Total assets$5.3M-19.9%

Cash flow

See full
Operating cash flow-$141.9K+93.9%
CapEx$29.5K
Free cash flow-$928.9K

Valuation

See full
Market cap$78.92M+472%
P/S758.1×

Profitability

See full
Gross margin100%
Operating margin-76,651.5%
Net margin-76,679.5%

Returns & leverage

See full
Return on equity-113.3%-133pp
Current ratio-0.8×

Where this comes from

Reported directly by Solidion Technology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DeferredOfferingCosts.

The official record: Solidion Technology, Inc.’s 10-Q, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solidion Technology, Inc.'s deferred offering costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Solidion Technology, Inc.'s deferred offering costs?
Solidion Technology, Inc. (STI) reported deferred offering costs of $460.92K in Q1 2026.